Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit.

This document provides information about a clinical study on the treatment of Genitourinary Syndrome of Menopause (GSM). The study is in the interventional phase and follows a randomized design. The two treatment options being compared are a Cellular Matrix/A-CP-HA Kit and local estrogen therapy. The study aims to assess the effectiveness of these treatments through various measures, including validated scales, symptom records, and follow-up photography. The study is currently in the recruitment phase and is expected to be completed by August 2026. The eligibility criteria for participants are also outlined, and the study is being conducted in Spain. The document also includes administrative information such as study ID numbers and contact information for the responsible party. [Extracted from the article]